InsiderTradesSIGMA

PicksTOP Companies Executives Performance Blog Topics

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Private beta.

FRUSDEGBCHCAITESNLBENOSEFIDKAUATIEBRINJP+ 8 markets

Recommendations
Companies
Insiders
Performance
Backtest
Compare

Markets
Sectors
Top movers
Leaderboard
Clusters
Heatmap
Earnings radar
Archive

Methodology
How it works
Glossary
API docs
Status
Blog

Sign in
Create account
Portfolio
API keys
Alerts
Upgrade

Privacy
Terms
Cookies
Contact
About

Built in Paris. Public sources across 28 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-16. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

Theme: dark (range regime detected on CAC40 90d · as of 2026-05-26)

© 2026 Insiders TradesΣ·Private beta·Hosted on Vercel

All systems operational

InsidersTradesSigma

US US6,790 companies

US-Listed Companies

Regulator: SEC (Form 4).

Santé & Pharma · 37bn

Santé & Pharma · 24bn

Santé & Pharma · 20bn

Santé & Pharma · 10bn

Technologie · 547bn

Chimie & Matériaux · 1.6bn

INTERNATIONAL BUSINESS MACHINES CORP

Technologie · 206bn

INTERNATIONAL PAPER CO /NEW/

Chimie & Matériaux · 21bn

Technologie · 93m

← PreviousPage 64 of 136Next →

INTEVAC INC

Technologie

Technologie · 15m

Technologie · 219bn

Technologie · 219bn

INVO Bioscience, Inc.

Santé & Pharma

IO Biotech, Inc.

Santé & Pharma · 61m

ION Geophysical CORP

IOTA COMMUNICATIONS, INC.

IP Strategy Holdings, INC.

Médias & Communication · 5.3m

IPG Photonics CORP

Industrie · 4.4bn

Santé & Pharma · 18m

ISABELLA BANK Corp

Finance & Banque · 366m

Transport & Logistique

Énergie · 4.2bn

Industrie · 17bn

IVERIC bio, Inc.

Santé & Pharma

IZEA Worldwide, Inc.

Médias & Communication · 76m

Distribution & Commerce · 717m

Icahn Enterprises L.P.

Autres · 5.5bn

Ichor Holdings, Ltd.

Industrie · 635m

Iconic Sports Acquisition Corp.

Iconix Brand Group, INC.

Industrie · 4.9m

Santé & Pharma

Idaho Strategic Resources, Inc.

Chimie & Matériaux · 604m

Ideal Power Inc.

Technologie · 74m

Ideanomics, INC.

Transport & Logistique

Technologie · 91m

Idera Pharmaceuticals, INC.

Santé & Pharma

Idexx Laboratories INC /de

Santé & Pharma · 54bn

Ikena Oncology, Inc.

Santé & Pharma

Illinois Tool Works INC

Industrie · 71bn

Santé & Pharma · 22bn

Image Sensing Systems INC

Imageware Systems INC

Technologie · 6.8m

Imago BioSciences, Inc.

Santé & Pharma